Healthcare provider profile · identity verified

Marisol D Casas Buchillon, ARNP

Nurse Practitioner · MIAMI GARDENS, FL · NPI 1003328600

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	437	166
Losartan Potassium	Losartan Potassium	283	109
Metformin Hcl	Metformin Hcl	245	95
Gabapentin	Gabapentin	185	69
Amlodipine Besylate	Amlodipine Besylate	160	61
Hydrochlorothiazide	Hydrochlorothiazide	155	53
Memantine Hcl	Memantine Hcl	143	49
Vitamin D2	Ergocalciferol (Vitamin D2)	139	52
Lisinopril	Lisinopril	137	54
Metoprolol Succinate	Metoprolol Succinate	135	47
Omeprazole	Omeprazole	129	53
Rosuvastatin Calcium	Rosuvastatin Calcium	118	49
Albuterol Sulfate Hfa	Albuterol Sulfate	116	38
Diclofenac Sodium	Diclofenac Sodium	104	37
Pantoprazole Sodium	Pantoprazole Sodium	104	41
Meclizine Hcl	Meclizine Hcl	97	39
Famotidine	Famotidine	93	36
Ketoconazole	Ketoconazole	91	26
Montelukast Sodium	Montelukast Sodium	90	36
Escitalopram Oxalate	Escitalopram Oxalate	87	26
Clopidogrel	Clopidogrel Bisulfate	85	34
Levothyroxine Sodium	Levothyroxine Sodium	85	32
Alendronate Sodium	Alendronate Sodium	80	26
Eliquis	Apixaban	78	18
Mirtazapine	Mirtazapine	78	29
Tamsulosin Hcl	Tamsulosin Hcl	74	26
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	72	24
Ozempic	Semaglutide	72	17
Fluticasone Propionate	Fluticasone Propionate	67	19
Farxiga	Dapagliflozin Propanediol	66	19
Glipizide	Glipizide	59	27
Trazodone Hcl	Trazodone Hcl	55	22
Azithromycin	Azithromycin	53	45
Simvastatin	Simvastatin	53	17
Meloxicam	Meloxicam	51	39
Sertraline Hcl	Sertraline Hcl	49	25
Furosemide	Furosemide	48	19
Enalapril Maleate	Enalapril Maleate	47	15
Nifedipine Er	Nifedipine	47	14
Donepezil Hcl	Donepezil Hcl	46	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	18
Carvedilol	Carvedilol	45	20
Pioglitazone Hcl	Pioglitazone Hcl	44	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	40	12
Sildenafil Citrate	Sildenafil Citrate	40	suppressed
Baclofen	Baclofen	39	19
Clonidine Hcl	Clonidine Hcl	39	15
Latanoprost	Latanoprost	39	11
Clobetasol Propionate	Clobetasol Propionate	38	11
Citalopram Hbr	Citalopram Hydrobromide	35	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	25
Ibuprofen	Ibuprofen	35	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	11
Buspirone Hcl	Buspirone Hcl	33	suppressed
Folic Acid	Folic Acid	33	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	33	12
Dutasteride	Dutasteride	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Atenolol	Atenolol	28	12
Ciclopirox	Ciclopirox	28	11
Tradjenta	Linagliptin	28	suppressed
Vascepa	Icosapent Ethyl	28	suppressed
Methocarbamol	Methocarbamol	27	23
Metronidazole	Metronidazole	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Ammonium Lactate	Ammonium Lactate	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Clonazepam	Clonazepam	25	15
Mupirocin	Mupirocin	25	18
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Pentoxifylline	Pentoxifylline	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Methylprednisolone	Methylprednisolone	23	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Jardiance	Empagliflozin	22	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	22	suppressed
Alprazolam	Alprazolam	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Celecoxib	Celecoxib	18	14
Dicyclomine Hcl	Dicyclomine Hcl	18	12
Ezetimibe	Ezetimibe	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Tadalafil	Tadalafil	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Cilostazol	Cilostazol	17	suppressed
Finasteride	Finasteride	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Linzess	Linaclotide	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	11
Bumetanide	Bumetanide	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Potassium Chloride	Potassium Chloride	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Hydroxyurea	Hydroxyurea	13	suppressed
Levofloxacin	Levofloxacin	13	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Temazepam	Temazepam	13	suppressed
Amoxicillin	Amoxicillin	12	11
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	11
Fluconazole	Fluconazole	11	suppressed
Juluca	Dolutegravir/Rilpivirine	11	suppressed
Lactulose	Lactulose	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error